Financing |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financing | 7. FINANCING
The 2025 Notes will mature in the next twelve months and have been reclassified to current portion of long-term debt from long-term debt in the Condensed Consolidated Balance Sheets as of June 30, 2024. See Note 8 within the Company’s audited consolidated financial statements included in the 2023 Annual Report for additional information on the terms and conditions of the Company’s debt obligations. Senior Secured Credit Facilities During the three and six months ended June 30, 2024, the Company made the quarterly scheduled amortization payments totaling $8.0 million and $16.0 million, respectively, on the Company's senior secured term loan due 2026 (the 2026 Term Loan). The current portion of long-term debt reflects repayments due under the 2026 Term Loan of $32.0 million and the 2025 Notes as described above. As of June 30, 2024, the Company did not reflect any portion of the 2026 Term Loan as a current portion of long-term debt related to the potentially required excess cash flow payment because the amount that may be payable in 2024, if any, cannot currently be reliably estimated. There is no excess cash flow payment required in 2024 related to 2023. During the six months ended June 30, 2024, the Company did not borrow under the Revolving Credit Facility. As of June 30, 2024, the Company had no outstanding borrowings under the Revolving Credit Facility and had availability of $535.4 million, after giving effect to borrowing base limitations and outstanding letters of credit. Other Matters The Company’s non-guarantor subsidiaries held $2,760 million, or 31%, of total assets and $657 million, or 6%, of total liabilities as of June 30, 2024 and accounted for $446 million, or 32% and $802 million, or 31%, of net sales for the three and six months ended June 30, 2024, respectively. All amounts presented exclude intercompany balances. The weighted average effective interest rate on outstanding borrowings, including the impact of the interest rate swap contracts and the amortization of debt issuance costs and original issue discount, was 7.22% as of both June 30, 2024 and December 31, 2023. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||